((自动化翻译由路透提供，请见免责声明 )) (第2段增加股票，第4-6段增加业绩细节)
路透10月29日 -
透析公司DaVita 周二公布的第三季度利润不及华尔街预期，受病人护理成本高企的影响。
收盘后，该公司股价下跌7.1%，报147美元。
根据 LSEG 统计的数据，调整后的第三季度利润为每股 2.59 美元，低于分析师预计的每股 2.73 美元。
该公司重申其年度利润预期为每股 9.25 美元至 10.05 美元。
DaVita 公布的季度收入为 32.6 亿美元，与分析师预计的 32.5 亿美元基本一致。
DaVita 通过门诊诊所网络和居家透析服务，为美国慢性肾衰竭患者提供肾脏护理服务。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.